Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6

Immutep Ltd Sponsored ADR +8.82%

Immutep Ltd Sponsored ADR

IMMP

0.59

+8.82%

Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ: IMMP) with a Market Outperform rating and announces Price Target of $6.